Other CF product revenues — Product revenues, net
Vertex Pharmaceuticals Other CF product revenues — Product revenues, net decreased by 42.8% to $135.9M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $155.3M to $135.9M. Over 2 years (FY 2022 to FY 2025), Other CF product revenues — Product revenues, net shows a downward trend with a -19.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful commercialization or market penetration of secondary assets, while a decrease may indicate declining demand for legacy products or a strategic shift in focus.
Detailed definition
This metric represents the net revenue generated from secondary or non-core pharmaceutical product lines outside of the...
Peer comparison
Peers often report this as 'Other Revenue' or 'Non-Core Product Sales,' and it is typically compared against the revenue growth rates of primary therapeutic franchises to determine portfolio balance.
vrtx_segment_other_product_revenues_product_revenues_netHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $310.98M | $310.98M | $310.98M | $310.98M | $209.2M | $184.4M | $207M | $196.4M | $186.9M | $191.2M | $155.3M | $236.1M | $175.8M | $237.4M | $135.9M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -32.7% | -11.9% | +12.3% | -5.1% | -4.8% | +2.3% | -18.8% | +52.0% | -25.5% | +35.0% | -42.8% |
| YoY Change | — | — | — | — | -32.7% | -40.7% | — | — | -10.7% | +3.7% | -25.0% | +20.2% | -5.9% | +24.2% | -12.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other cf product revenues — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported other cf product revenues — product revenues, net of $135.9M in Q1 2026.
- How has Vertex Pharmaceuticals's other cf product revenues — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's other cf product revenues — product revenues, net decreased by 12.5% year-over-year, from $155.3M to $135.9M.
- What is the long-term trend for Vertex Pharmaceuticals's other cf product revenues — product revenues, net?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's other cf product revenues — product revenues, net has grown at a -19.6% compound annual growth rate (CAGR), from $1.24B to $804.6M.
- What does other cf product revenues — product revenues, net mean?
- Net revenue generated from the company's secondary or non-core pharmaceutical product offerings.